Rede D’Or São Luiz S.A.

What it is

Rede D’Or began in 1977 as a cardiology diagnostic lab in Rio de Janeiro and scaled into Latin America’s largest private hospital platform by buying, building, and standardising hospitals across Brazil’s wealthiest urban markets. It now operates 51 owned hospitals, one managed hospital, and 47 oncology clinics with 9,000 beds, in states spanning Rio de Janeiro, São Paulo, Pernambuco, Bahia, Maranhão, Sergipe, Ceará, Paraná, and the Federal District.

The group runs three main lines of business: hospitals (its own facilities, managed sites, and oncology clinics); health insurance and dental plans; and life and pension products. The insurance arm came largely via its 2022–23 acquisition of SulAmérica, which turned Rede D’Or from a pure hospital operator into a combined insurer-and-provider under one roof.

Who owns it

As of September 30, 2025, the Moll family directly and indirectly owned 47.6% of the company’s shares, while the free float was equivalent to 45.9%. Shares held by management and in treasury totalled 4.8%.

Singapore’s sovereign wealth fund GIC holds a board seat through Wolfgang Schwerdtle, responsible for GIC’s Brazil office. Voting follows Novo Mercado’s one-share-one-vote model, strengthening minority protections, yet the family’s concentrated stake drives outcomes on major strategic decisions.

Who runs it

Paulo Moll — son of founder Jorge Moll Filho — joined the company in 2001 and serves as Chief Executive Officer; he holds a bachelor’s degree in economics from IBMEC. CFO and Investor Relations Officer Otávio de Garcia Lazcano joined in 2015, having previously served as treasurer at Aracruz Celulose and financial director at Companhia Siderúrgica Nacional (CSN) from 2001 to 2009.

Jorge Moll Filho, the cardiologist who founded the business in 1977, has served as president of the board of directors since the company’s founding. In line with best governance practice, the chairman of the board does not sit on the executive board.

The money, in plain words

Sales have grown fast: revenue rose from R$46.5bn (US$9.0 bn) in 2023 to R$55.7bn (US$10.8 bn) in 2025 — a gain of about 20% over two years (our calculation), driven by bed additions, higher procedure volumes, and the full consolidation of SulAmérica’s insurance premiums. The business keeps about 8 cents of profit from every real of sales — a net margin of 8.1% — which is solid for a capital-intensive hospital operator, though well below what a pure insurer might post.

For every real of equity owners have put in, it earns roughly 19 back a year — a return on equity of 19.2%, strong for the sector. The main caution is the debt: net debt stands at R$49.2bn (~US$9.6bn) against equity of R$19.4bn (US$3.8 bn), a legacy of years of acquisitions (our calculation).

The 12.9% dividend yield is striking and reflects the company returning capital aggressively — investors should confirm whether it is sustained by operating cash flow or partly funded by the balance sheet.

What it is doing now

The most active strategic thread is the Atlântica D’Or joint venture with Bradesco’s health arm; the partnership now totals 2,100 beds across a growing portfolio of hospitals, with Rede D’Or holding a 50.01% stake. In November 2025, the premium Maternidade Star unit was transferred into the joint venture in a transaction in which Atlântica paid R$223m (US$43 mn) to the Moll family’s hospital group.

Separately, the company plans to invest R$7.5bn (US$1.5 bn) by 2028 to add 5,400 new hospital beds, a 46% capacity increase focused on organic growth and raising average hospital size to 200 beds. Locking in Bradesco — one of Brazil’s two largest private health insurers — as a co-investor is a deliberate hedge: it guarantees patient referrals while sharing the capital cost of new hospitals.

What to watch

• Debt service. Net debt of R$49.2bn (~US$9.6bn) in a high-Brazilian-interest-rate environment makes refinancing cost the single biggest drag on earnings growth.
• Insurance integration. The SulAmérica merger thesis rests on cutting medical costs by routing insured patients into Rede D’Or hospitals; whether that margin uplift materialises — and when — is the key question for the combined P&L.
• Atlântica D’Or pipeline. The joint venture currently holds five hospitals, with scope for at least two more assets and an expanding joint expansion plan. Each addition tests the group’s ability to ramp occupancy fast enough to service the capital invested.
• Dividend sustainability. A 12.9% yield demands scrutiny; track the payout ratio and free cash flow conversion each quarter.

This is news, not investment advice.